Jefferies Group’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Jefferies Group’s Portfolio LKFT Stock Details LKFT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-35,000	Closed	-$6.91K	–	1419
2020 Q2	$6.91K	Sell	35,000 -50,000	-59%	-$10.4M	0.08%	210
2020 Q1	$16.7M	Buy	+85,000	New	+$18.3M	0.18%	73
2019 Q2	–	Sell	-185,000	Closed	-$21.8M	–	2647
2019 Q1	$21.8M	Buy	+185,000	New	+$18.7M	0.18%	76
2018 Q4	–	Sell	-1,400	Closed	-$157K	–	2297
2018 Q3	$157K	Buy	+1,400	New	+$148K	﹤0.01%	2155

Other funds holding LKFT

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bessemer Group Woodbridge, New Jersey $63.6B AUM 28.76% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

OMC

Old Mission Capital Chicago, Illinois $6.3B AUM 14.68% 1-Year Est. Return

Jefferies Group's LKFT Position: Q3 2020 in Review

Jefferies Group sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q3 2020, closing a stake of 2,039 shares — an estimated $402 sold.

Jefferies Group first reported a position in LKFT in Q4 2017 and held it in 6 quarters. The position peaked at $1.01M in Q4 2017. 119 funds tracked by Wall St. Rank hold LKFT as of Q3 2020.

Jefferies Group reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q3 2020 after selling out during the quarter.
Jefferies Group sold 2,039 Lakefront Biotherapeutics American Depositary Shares shares in Q3 2020, an estimated $402.
Jefferies Group first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q4 2017 and held it in 6 quarters.
Jefferies Group's Lakefront Biotherapeutics American Depositary Shares position peaked at $1.01M in Q4 2017.
119 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q3 2020.

Based on Jefferies Group's 13F filing for Q3 2020, filed 13 Nov 2020.